1Owayed Al Shammeri,1Bilal Hayek, 1Asel Budaichieva, 1Abdullah Alwehbi

1Habib Medical Group

Background(s):

End Stage Renal Disease Patients with Arteriovenous Fistula (AVF) encounter many vascular risk related to reduced or increase arteriovenous fistula flow. Dialysis Access-Associated steal syndrome is one of devastating complication which may lead to limb loss. There are multiple vascular techniques to correct this complication. We present in this article two endovascular approaches with 12-month follow up. One by using stent graft covering two thirds of anastomosis of arteriovenous fistula generating artificial stenosis diverting more flow to the hand. The other approach is by using Supera stent jailing the arteriovenous fistula diverting more flow to the hand.

Material(s) and Method(s):

We studied the long-term outcome of two endovascular techniques to treat Dialysis Access-Associated steal syndrome (Stent graft or Supera self expandable nitinol inetrwoven wire stent).

Result(s):

12 month follow up showed functioning AV fistula with no clinical manifestation of Dialysis Access-Associated steal syndrome.

Conclusion(s):

We described two endovascular techniques to treat dialysis associated steal syndrome with durable long term ourtcome (12 month follow up). Endovascular innovation continues to save AV fistula to be more durable